乌斯特基努马布治疗性结肠炎:全国性的现实生活观察队列研究
Pauliina Molander1, Clas-Göran Af Björkesten1, Hans Henricson2
1Department of Gastroenterology, Abdominal Center, University of Helsinki and Helsinki University Hospital, Helsinki.
乌斯特基努马布在芬兰的性结肠炎患者中显示出持续的有效性. 现实世界的数据表明,高治疗持久性和显著的临床缓解率在1年.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病.
- 对UC的有效的长期治疗选择至关重要.
- 乌斯特基努马布是一种新兴的生物疗法,用于中度至重度的UC.
研究的目的:
- 评估芬兰UC患者的乌斯特基努马布治疗持久性.
- 评估ustekinumab治疗的临床结果,包括缓解率.
- 分析乌斯特基努马布在UC管理中的实际有效性.
主要方法:
- 在芬兰,对221名UC患者进行了全国性的回顾性图表审查.
- 2019年9月至2021年12月期间,从16个中心收集的数据.
- 主要结局:16周和1年后的乌斯特基努马布持久性和临床/无类固醇缓解.
主要成果:
- 治疗持久度高:在16周时87%,在1年时63%.
- 显著的缓解率:49%/46%的临床/无类固醇在16周,68%/62%在52周.
- 观察到减少皮质类固醇的使用和便calprotectin水平.
结论:
- 乌斯特基努马布在现实世界UC治疗中表现出持续的疗效.
- 该疗法耐受性良好,抗体和不良事件的比例较低.
- 乌斯特基努马布为性结肠炎提供了一种可行的长期治疗选择.
更多相关视频
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
09:42Murine Endoscopy for In Vivo Multimodal Imaging of Carcinogenesis and Assessment of Intestinal Wound Healing and Inflammation
Published on: August 26, 2014
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
